SBI Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 17 Nov 2017 132.53 1.20
(0.91%)

NAV High-Low (in Rs)

ONE Mth 1053.91
1053.91
52-WEEk 847.18
1068.58

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - - 3.08
Sensex 0.08 2.25 8.75 27.13 18.33
Nifty -0.37 0.48 7.96 27.27 21.98

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 31 Oct 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.02
CBLO 2.94
Equity 97.50
› More
   As On 31 Oct 2017
Sector Name Amount
Healthcare 12.16
NA 2.96
Pharmaceuticals - Indian - Bulk Drugs 15.80
Pharmaceuticals - Indian - Bulk Drugs & Formln 58.96
Pharmaceuticals - Indian - Formulations 7.61
Pharmaceuticals - Multinational 2.97
› More
   As On 31 Oct 2017
Company Name
Cipla 10.24
Divi's Lab. 10.05
Aurobindo Pharma 9.74
Strides Shasun 7.08
Dr Reddy's Labs 6.91
Natco Pharma 5.88
Cadila Health. 5.73
Alkem Lab 4.44
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com